📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer. (2019)

First Author: Carter R

Attributed to: Novel strategies to improve the effectiveness of radiation and targeted therapies in lung cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0284

PubMed Identifier: 31516745

Publication URI: http://europepmc.org/abstract/MED/31516745

Type: Journal Article/Review

Volume: 16

Parent Publication: Cancer biology & medicine

Issue: 2

ISSN: 2095-3941